CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Down 86.7% in November

CV Sciences, Inc. (OTCMKTS:CVSI) was the recipient of a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 7,900 shares, a decrease of 86.7% from the November 15th total of 59,400 shares. Based on an average trading volume of 321,200 shares, the short-interest ratio is presently 0.0 days.

CV Sciences Stock Performance

Shares of CVSI stock remained flat at $0.03 during mid-day trading on Friday. 207,129 shares of the stock traded hands, compared to its average volume of 240,495. The company has a 50-day simple moving average of $0.04 and a 200 day simple moving average of $0.05. CV Sciences has a 1 year low of $0.03 and a 1 year high of $0.10.

CV Sciences Company Profile

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.